Manchester Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,404
Closed -$1.03M 552
2019
Q3
$1.03M Buy
10,404
+636
+7% +$60.4K 0.12% 90
2019
Q2
$903K Hold
9,768
0.12% 101
2019
Q1
$922K Buy
9,768
+120
+1% +$10.5K 0.12% 92
2018
Q4
$766K Hold
9,648
0.12% 103
2018
Q3
$863K Hold
9,648
0.12% 89
2018
Q2
$766K Buy
9,648
+8,422
+687% +$699K 0.12% 104
2018
Q1
$109K Buy
1,226
+38
+3% +$3.65K 0.02% 268
2017
Q4
$124K Hold
1,188
0.02% 241
2017
Q3
$173K Hold
1,188
0.03% 198
2017
Q2
$154K Hold
1,188
0.02% 217
2017
Q1
$148K Hold
1,188
0.02% 221
2016
Q4
$138K Hold
1,188
0.02% 227
2016
Q3
$124K Sell
1,188
-1,312
-52% -$142K 0.02% 246
2016
Q2
$247K Hold
2,500
0.04% 171
2016
Q1
$250K Hold
2,500
0.03% 175
2015
Q4
$299K Hold
2,500
0.04% 170
2015
Q3
$270K Hold
2,500
0.05% 162
2015
Q2
$289K Hold
2,500
0.05% 169
2015
Q1
$288K Sell
2,500
-926
-27% -$111K 0.05% 166
2014
Q4
$383K Hold
3,426
0.05% 212
2014
Q3
$325K Hold
3,426
0.04% 228
2014
Q2
$294K Hold
3,426
0.04% 275
2014
Q1
$239K Sell
3,426
-20
-0.6% -$1.58K 0.04% 293
2013
Q4
$291K Hold
3,446
0.05% 253
2013
Q3
$266K Sell
3,446
-208
-6% -$14.6K 0.05% 272
2013
Q2
$214K Buy
+3,654
New +$220K 0.04% 292

Other funds holding CELG

Manchester Capital Management's CELG Position: Q4 2019 in Review

Manchester Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,404 shares — an estimated $1.03M sold.

Manchester Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.03M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Manchester Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Manchester Capital Management sold 10,404 Celgene Corp shares in Q4 2019, an estimated $1.03M.
  • Manchester Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Manchester Capital Management's Celgene Corp position peaked at $1.03M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Manchester Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.